Wells Fargo & Company Kezar Life Sciences, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 78,162 shares of KZR stock, worth $512,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,162
Previous 79,512 1.7%
Holding current value
$512,742
Previous $47,000 27.66%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.53 - $0.77 $715 - $1,039
-1,350 Reduced 1.7%
78,162 $60,000
Q2 2024

Aug 13, 2024
SELL
$0.6 - $0.92 $6,112 - $9,372
-10,188 Reduced 11.36%
79,512 $47,000
Q1 2024

May 10, 2024
SELL
$0.8 - $1.05 $4,892 - $6,420
-6,115 Reduced 6.38%
89,700 $80,000
Q4 2023

Feb 09, 2024
SELL
$0.72 - $1.15 $14,880 - $23,768
-20,668 Reduced 17.74%
95,815 $91,000
Q3 2023

Nov 13, 2023
BUY
$1.08 - $2.54 $15,009 - $35,300
13,898 Added 13.55%
116,483 $138,000
Q2 2023

Aug 15, 2023
BUY
$2.31 - $3.06 $5,657 - $7,493
2,449 Added 2.45%
102,585 $251,000
Q1 2023

May 12, 2023
BUY
$3.13 - $7.31 $181,674 - $424,294
58,043 Added 137.89%
100,136 $313,000
Q4 2022

Feb 13, 2023
SELL
$6.39 - $8.8 $28,601 - $39,388
-4,476 Reduced 9.61%
42,093 $296,000
Q3 2022

Nov 14, 2022
SELL
$7.99 - $10.75 $320,726 - $431,515
-40,141 Reduced 46.29%
46,569 $400,000
Q2 2022

Aug 12, 2022
SELL
$4.58 - $17.13 $145,909 - $545,727
-31,858 Reduced 26.87%
86,710 $717,000
Q1 2022

May 16, 2022
SELL
$12.3 - $18.33 $375,801 - $560,036
-30,553 Reduced 20.49%
118,568 $1.97 Million
Q4 2021

Feb 14, 2022
SELL
$7.44 - $16.72 $770,709 - $1.73 Million
-103,590 Reduced 40.99%
149,121 $2.49 Million
Q3 2021

Nov 15, 2021
BUY
$4.85 - $9.73 $52,360 - $105,045
10,796 Added 4.46%
252,711 $2.18 Million
Q2 2021

Aug 16, 2021
SELL
$4.93 - $6.46 $72,199 - $94,606
-14,645 Reduced 5.71%
241,915 $1.31 Million
Q1 2021

May 13, 2021
SELL
$5.24 - $6.99 $302,096 - $402,987
-57,652 Reduced 18.35%
256,560 $1.53 Million
Q4 2020

Feb 09, 2021
BUY
$4.77 - $6.58 $408,951 - $564,129
85,734 Added 37.52%
314,212 $1.64 Million
Q3 2020

Nov 05, 2020
SELL
$4.36 - $5.5 $341,902 - $431,299
-78,418 Reduced 25.55%
228,478 $1.11 Million
Q2 2020

Aug 13, 2020
BUY
$3.6 - $7.75 $846,655 - $1.82 Million
235,182 Added 327.94%
306,896 $1.59 Million
Q1 2020

May 14, 2020
BUY
$2.77 - $5.75 $198,647 - $412,355
71,714 New
71,714 $312,000

Others Institutions Holding KZR

# of Institutions
61
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $449M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email